Howard C. Thomas

26.8k citations

327 papers · 19.5k indexed · 5 hit papers · h-index 68

Impact in

Hepatology top 0.02%
- Hepatitis C virus research
- Hepatitis Viruses Studies and Epidemiology
- Liver Disease and Transplantation
- Liver Diseases and Immunity
Epidemiology top 0.05%
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment

Papers in

Hepatology 234
- Hepatitis C virus research 173
- Liver Disease and Transplantation 37
- Hepatitis Viruses Studies and Epidemiology 35
- Liver Diseases and Immunity 28
Epidemiology 260
- Hepatitis B Virus Studies 182
- Liver Disease Diagnosis and Treatment 138

Co-authors: Peter Karayiannis Simon D. Taylor‐Robinson Shahid A. Khan Robert Goldin William F. Carman Brian R Davidson Graham R. Foster J. Monjardino
Journals: Journal of Hepatology (38 papers)Hepatology (36 papers)Journal of Medical Virology (28 papers)Gut (24 papers)Journal of Viral Hepatitis (19 papers)
Partner nations: United Kingdom United States Italy

In The Last Decade

Howard C. Thomas

324 papers receiving 18.5k citations

Hit Papers

5 papers align trajectories log scale

Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update 2012 · 597 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2012 Gut
2005 The Lancet
1996 Proceedings of the National Academy of Sciences
1990 The Lancet
1989 The Lancet

Peers

Countries citing papers authored by Howard C. Thomas

Since Specialization

Citations

This map shows the geographic impact of Howard C. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Howard C. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Howard C. Thomas more than expected).

Fields of papers citing papers by Howard C. Thomas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Howard C. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Howard C. Thomas. The network helps show where Howard C. Thomas may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Howard C. Thomas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Howard C. Thomas Line = papers co-authored together Howard C. Thomas links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update Gut ·Shahid A. Khan, Brian R Davidson, Robert Goldin, Nigel Heaton, John Karani, Stephen P. Pereira, William Rosenberg, Paul Tait, Simon D. Taylor‐Robinson, Andrew V. Thillainayagam, Howard C. Thomas, Harpreet Wasan Hit paper breakdown →	2012	597
2	The treatment effect of alpha interferon in chronic hepatitis B is independent of pre-treatment variables. Results based on individual patient data from 10 clinical controlled trials Journal of Hepatology ·Kim Krogsgaard, (unknown), Niels Bindslev, Erik Christensen, Antonio Craxı̀, P. Schlichting, Solko W. Schalm, Vicente Carréño, C. Trépo, Guido Gerken, Howard C. Thomas, Per Kragh Andersen, Helmer Ring‐Larsen	1994	70
3	Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons alpha and gamma and double-stranded RNA. Proceedings of the National Academy of Sciences ·Graham R. Foster, Andrew M. Ackrill, Robert Goldin, Ian M. Kerr, Howard C. Thomas, George R. Stark	1991	128
4	Randomised controlled trial of interferon alfa (lymphoblastoid interferon) in chronic non-A non-B hepatitis. BMJ ·M R Jacyna, Aleksey Vyngra, Parviz Dousti Kataj, Janice Main, Iain M. Murray‐Lyon, Howard C. Thomas	1989	109
5	Subclasses of antibodies to hepatitis B core antigen in chronic HBV infection: changes during treatment with alpha interferons and predictors of response. Gut ·Milan Dvořák, Peter Karayiannis, Michael J. McGarvey, Andrew Lever, J.A. McDonald, Linda Scully, Gerard A Butzen, Howard C. Thomas	1989	9
6	Clinical and histological features of delta infection in chronic hepatitis B virus carriers. Journal of Clinical Pathology ·Anna S. Lok, Iain Lindsay, Peter J. Scheuer, Howard C. Thomas	1985	31
7	Hepatitis B virus DNA in saliva, urine, and seminal fluid of carriers of hepatitis B e antigen. BMJ ·Peter Karayiannis, David M. Novick, Anna S. Lok, Martin Fowler, J. Monjardino, Howard C. Thomas	1985	58
8	Acute fulminant non-A, non-B hepatitis leading to chronic active hepatitis after treatment with cryoprecipitate. Gut ·Katsushige Mizunq, P. B. A. Kernoff, Peter Karayiannis, Howard C. Thomas	1985	5
9	In vitro and in vivo cytotoxic activity of native and ricin conjugated monoclonal antibodies to HBs antigen for Alexander primary liver cell carcinoma cells and tumours. Gut ·Madina Rakhmatova, Alison H. Goodall, Kassyane Lourenço, 琴江鈴木, David Brown, Howard C. Thomas	1984	7
10	Clinical, biochemical, serological, histological and ultrastructural features of liver disease in drug abusers. Gut ·Ian Weller, David L. Cohn, Serdar Tez, Nontoko Ngxulumu, M G Ross, Luis F. Montaño, I. Zajicek, Howard C. Thomas	1984	21
11	Analysis of the molecular state of HBV-DNA in the liver and serum of patients with chronic hepatitis or primary liver cell carcinoma and the effect of therapy with adenine arabinoside. Gut ·Martin Fowler, J. Monjardino, Ian Weller, Anna S. Lok, Howard C. Thomas	1984	26
12	Significance of delta agent infection in chronic hepatitis B virus infection: a study in British carriers. Gut ·I V Weller, Peter Karayiannis, Anna S. Lok, Luis F. Montaño, M Bamber, Howard C. Thomas, S. Sherlock	1983	34
13	Complement activation in chronic liver disease. PubMed Central ·Luis E. Muñoz, Nanna Hundebøll, Ping Yu, K Whaley, Howard C. Thomas	1982	28
14	Primary liver cell cancer in autoimmune chronic liver disease. BMJ ·Andrew K. Burroughs, M.F. Bassendine, Howard C. Thomas, Sheila Sherlock	1981	22
15	Short incubation non-A, non-B hepatitis transmitted by factor VIII concentrates in patients with congenital coagulation disorders. Gut ·M Bamber, Alison D. Murray, Bengt Arborgh, Peter J. Scheuer, P. B. A. Kernoff, Howard C. Thomas, Sheila Sherlock	1981	56
16	Late results of the Royal Free Hospital prospective controlled trial of prednisolone therapy in hepatitis B surface antigen negative chronic active hepatitis. Gut ·Andrew Kirk, Shubham Jain, Kellee Parker, Howard C. Thomas, S. Sherlock	1980	192
17	Immune complexes in acute and chronic liver disease. PubMed Central ·Howard C. Thomas, Nanna Hundebøll, Barry J. Potter, Matthew Lambert, S Jain, D P Jewell, S. Sherlock	1978	129
18	Lymphocyte populations in liver biopsy specimens from patients with chronic liver disease. Gut ·José‐María Sánchez‐Tapias, Howard C. Thomas, S. Sherlock	1977	53
19	The immune response in cirrhotic rats. Antigen distribution, humoral immunity, cell-mediated immunity and splenic suppressor cell activity. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Howard C. Thomas, Charles R.J. Singer, Nicholas L. Tilney, Hugo Folch, R N MacSween	1976	19
20	Antibodies to Escherichia coli in chronic liver diseases. Gut ·Tran T. Ha, S. G. Lucas, Howard C. Thomas, W. Brumfitt, S Sherlock	1975	24

About Howard C. Thomas

Howard C. Thomas is a scholar working on Hepatology, Epidemiology, Virology, Animal Science and Zoology and Infectious Diseases, having authored 327 papers that have together received 19.5k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (182 papers), Hepatitis C virus research (173 papers), Liver Disease Diagnosis and Treatment (138 papers), Liver Disease and Transplantation (37 papers), Hepatitis Viruses Studies and Epidemiology (35 papers), Liver Diseases and Immunity (28 papers), Viral gastroenteritis research and epidemiology (22 papers) and HIV Research and Treatment (17 papers). The work is most often cited by research in Hepatology (12.1k citations), Epidemiology (12.5k citations), Virology (774 citations), Infectious Diseases (1.8k citations) and Immunology (1.8k citations). Howard C. Thomas has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Peter Karayiannis, Simon D. Taylor‐Robinson, Shahid A. Khan, Robert Goldin, William F. Carman, Brian R Davidson, Graham R. Foster, J. Monjardino, Mark Thursz and Jennifer A. Waters. Their work appears in journals such as Journal of Hepatology, Hepatology, Journal of Medical Virology, Gut and Journal of Viral Hepatitis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact